John Tukianen

Company: Amylyx Pharmaceuticals Corp.

Job title: Lead Development Engineer

Seminars:

Considerations for selection of a CDMO to reproducibly manufacture a low endotoxin antisense oligonucleotide for intrathecal injection 3:00 pm

Managing analytical/process development and manufacturing virtually Sources of endotoxin introduction and facility/equipment/process designs to reproducibly control to low endotoxin thresholds How your IT bolus and dosing strategy will define DS and DP endotoxin specifications at your CDMORead more

day: Conference Day Two